• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非酒精性脂肪性肝病患者的慢性肾脏病:肝病学家应该知道什么?

Chronic kidney disease in patients with non-alcoholic fatty liver disease: What the Hepatologist should know?

机构信息

4th Department of Internal Medicine, School of Medicine, Aristotle University of Thessaloniki, Hippokration General Hospital of Thessaloniki, Konstantinoupoleos, Thessaloniki, Greece.

4th Department of Internal Medicine, School of Medicine, Aristotle University of Thessaloniki, Hippokration General Hospital of Thessaloniki, Konstantinoupoleos, Thessaloniki, Greece.

出版信息

Ann Hepatol. 2020 Mar-Apr;19(2):134-144. doi: 10.1016/j.aohep.2019.07.013. Epub 2019 Sep 23.

DOI:10.1016/j.aohep.2019.07.013
PMID:31606352
Abstract

The association of non-alcoholic fatty liver disease (NAFLD) with several other diseases has gained increased interest during the recent years. Among them, the association with chronic kidney disease (CKD) has emerged as an important one regarding both its prevalence and significance. The early recognition of this association is important for the prognosis of patients with NAFLD and CKD. Apart from early diagnosis, the accurate assessment of renal function is also crucial in the clinical practice of hepatologists. Several methods have been used in the literature for the evaluation of kidney function in patients with NAFLD up to now. In this respect, calculators (or formulas) for the estimation of Glomerular Filtration Rate (eGFR) and Albumin to Creatinine Ratio (ACR) are simple, practical and easily available methods for this purpose. The aim of this review is to report on the epidemiology and pathophysiology of the relationship between NAFLD and CKD and to describe the different methods of kidney function assessment in patients with NAFLD. The collection of all relevant data regarding this association will provide hepatologists with pertinent knowledge on this topic and allow them to use the most accurate methods for the assessment of kidney function in these patients in their clinical practice.

摘要

非酒精性脂肪性肝病(NAFLD)与其他几种疾病的关联近年来引起了越来越多的关注。其中,与慢性肾脏病(CKD)的关联因其普遍性和重要性而成为一个重要的问题。早期认识到这种关联对于 NAFLD 和 CKD 患者的预后很重要。除了早期诊断外,准确评估肾功能在肝病学家的临床实践中也至关重要。迄今为止,文献中已经使用了多种方法来评估 NAFLD 患者的肾功能。在这方面,肾小球滤过率(eGFR)和白蛋白与肌酐比值(ACR)的计算器(或公式)是用于此目的的简单、实用且易于获得的方法。本综述的目的是报告 NAFLD 和 CKD 之间关系的流行病学和病理生理学,并描述评估 NAFLD 患者肾功能的不同方法。收集关于这种关联的所有相关数据将为肝病学家提供关于这个主题的相关知识,并使他们能够在临床实践中为这些患者评估肾功能时使用最准确的方法。

相似文献

1
Chronic kidney disease in patients with non-alcoholic fatty liver disease: What the Hepatologist should know?非酒精性脂肪性肝病患者的慢性肾脏病:肝病学家应该知道什么?
Ann Hepatol. 2020 Mar-Apr;19(2):134-144. doi: 10.1016/j.aohep.2019.07.013. Epub 2019 Sep 23.
2
Non-alcoholic fatty liver disease, metabolic goal achievement with incident cardiovascular disease and eGFR-based chronic kidney disease in patients with prediabetes and diabetes.非酒精性脂肪性肝病,糖尿病前期和糖尿病患者心血管疾病事件和基于 eGFR 的慢性肾脏病的代谢目标达标。
Metabolism. 2021 Nov;124:154874. doi: 10.1016/j.metabol.2021.154874. Epub 2021 Sep 10.
3
Non-invasive fibrosis assessments of non-alcoholic fatty liver disease associated with low estimated glomerular filtration rate among CKD patients: the Fukuoka Kidney disease Registry Study.非酒精性脂肪性肝病相关慢性肾脏病患者肾小球滤过率估计值低的非侵入性纤维化评估:福冈肾脏病登记研究。
Clin Exp Nephrol. 2021 Aug;25(8):822-834. doi: 10.1007/s10157-020-02018-z. Epub 2021 Apr 15.
4
Non-alcoholic fatty liver disease and clinical outcomes in chronic kidney disease.非酒精性脂肪性肝病与慢性肾脏病的临床转归。
Nephrol Dial Transplant. 2019 Mar 1;34(3):449-457. doi: 10.1093/ndt/gfx381.
5
Nonalcoholic fatty liver disease as a multi-systemic disease.非酒精性脂肪性肝病作为一种多系统疾病。
World J Gastroenterol. 2016 Apr 28;22(16):4079-90. doi: 10.3748/wjg.v22.i16.4079.
6
MAFLD and risk of CKD.MAFLD 和慢性肾脏病风险。
Metabolism. 2021 Feb;115:154433. doi: 10.1016/j.metabol.2020.154433. Epub 2020 Nov 16.
7
Intrahepatic triglyceride content is independently associated with chronic kidney disease in obese adults: A cross-sectional study.肝内甘油三酯含量与肥胖成年人慢性肾病独立相关:一项横断面研究。
Metabolism. 2015 Sep;64(9):1077-85. doi: 10.1016/j.metabol.2015.06.003. Epub 2015 Jun 10.
8
Non-Alcoholic Fatty Liver Disease Is Associated With Reduced Glomerular Filtration Rate in Patients With Chronic Plaque Psoriasis.非酒精性脂肪性肝病与慢性斑块状银屑病患者肾小球滤过率降低有关。
J Cutan Med Surg. 2022 May-Jun;26(3):249-255. doi: 10.1177/12034754211066906. Epub 2021 Dec 12.
9
The HSD17B13 rs72613567 variant is associated with lower levels of albuminuria in patients with biopsy-proven nonalcoholic fatty liver disease.经活检证实的非酒精性脂肪性肝病患者中,HSD17B13基因rs72613567变异与较低水平的蛋白尿相关。
Nutr Metab Cardiovasc Dis. 2021 Jun 7;31(6):1822-1831. doi: 10.1016/j.numecd.2021.02.018. Epub 2021 Feb 25.
10
Association of non-alcoholic fatty liver disease with chronic kidney disease: a systematic review and meta-analysis.非酒精性脂肪性肝病与慢性肾脏病的关联:一项系统评价和荟萃分析
PLoS Med. 2014 Jul 22;11(7):e1001680. doi: 10.1371/journal.pmed.1001680. eCollection 2014 Jul.

引用本文的文献

1
New insights into the role of metallothioneins in obesity and diabetes.金属硫蛋白在肥胖和糖尿病中作用的新见解。
Int J Obes (Lond). 2025 Jul 14. doi: 10.1038/s41366-025-01850-1.
2
Disease classification, diagnostic challenges, and evolving clinical trial design in MASLD.非酒精性脂肪性肝炎(MASLD)的疾病分类、诊断挑战及不断演变的临床试验设计
J Clin Invest. 2025 May 15;135(10). doi: 10.1172/JCI189953.
3
Targeting Insulin Resistance and Liver Fibrosis: CKD Screening Priorities in MASLD.针对胰岛素抵抗和肝纤维化:非酒精性脂肪性肝病相关慢性肾脏病的筛查重点
Biomedicines. 2025 Apr 1;13(4):842. doi: 10.3390/biomedicines13040842.
4
Nephrological, Pulmonary, and Dermatological Complications in the Context of MAFLD/NAFLD: A Narrative Review.MAFLD/NAFLD背景下的肾脏、肺部和皮肤并发症:一项叙述性综述
Metabolites. 2025 Apr 14;15(4):272. doi: 10.3390/metabo15040272.
5
From Liver to Kidney: The Overlooked Burden of Nonalcoholic Fatty Liver Disease in Chronic Kidney Disease.从肝脏到肾脏:慢性肾脏病中非酒精性脂肪性肝病被忽视的负担
J Clin Med. 2025 Apr 5;14(7):2486. doi: 10.3390/jcm14072486.
6
Machine learning applications in healthcare clinical practice and research.机器学习在医疗保健临床实践与研究中的应用。
World J Clin Cases. 2025 Jan 6;13(1):99744. doi: 10.12998/wjcc.v13.i1.99744.
7
The Renoprotective Mechanisms of Sodium-Glucose Cotransporter-2 Inhibitors (SGLT2i)-A Narrative Review.钠-葡萄糖共转运蛋白 2 抑制剂(SGLT2i)的肾保护机制:一篇叙述性综述。
Int J Mol Sci. 2024 Jun 27;25(13):7057. doi: 10.3390/ijms25137057.
8
Machine learning-based comparison of factors influencing estimated glomerular filtration rate in Chinese women with or without non-alcoholic fatty liver.基于机器学习对有无非酒精性脂肪肝的中国女性中影响估算肾小球滤过率的因素进行比较。
World J Clin Cases. 2024 May 26;12(15):2506-2521. doi: 10.12998/wjcc.v12.i15.2506.
9
Cold-Pressed Sacha Inchi Oil: High in Omega-3 and Prevents Fat Accumulation in the Liver.冷榨印加果油:富含欧米伽-3,可防止肝脏脂肪堆积。
Pharmaceuticals (Basel). 2024 Feb 7;17(2):220. doi: 10.3390/ph17020220.
10
TASL Practice Guidance on the Clinical Assessment and Management of Patients with Nonalcoholic Fatty Liver Disease.非酒精性脂肪性肝病患者临床评估与管理的TASL实践指南。
Hepatol Forum. 2023 Mar 15;4(Suppl 1):1-32. doi: 10.14744/hf.2023.2023.0011. eCollection 2023.